These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17048329)

  • 1. Readers' responses to "the cost of marginal medicine is too high".
    Fogarty WM
    MedGenMed; 2006; 8(2):44; author reply 43. PubMed ID: 17048329
    [No Abstract]   [Full Text] [Related]  

  • 2. Readers' responses to "the cost of marginal medicine is too high".
    Beard MR
    MedGenMed; 2006; 8(2):44; author reply 43. PubMed ID: 17048327
    [No Abstract]   [Full Text] [Related]  

  • 3. Readers' responses to "the cost of marginal medicine is too high".
    Pawelski LA
    MedGenMed; 2006; 8(2):44; author reply 43. PubMed ID: 17048330
    [No Abstract]   [Full Text] [Related]  

  • 4. Readers' and author's responses to "We all need healthcare; who needs 'insurance'?".
    Wood PG
    MedGenMed; 2007; 9(4):13; author reply 13. PubMed ID: 18320634
    [No Abstract]   [Full Text] [Related]  

  • 5. Readers' and author's responses to "We all need healthcare; who needs 'insurance'?".
    Martin P
    MedGenMed; 2007; 9(4):13; author reply 13. PubMed ID: 18320632
    [No Abstract]   [Full Text] [Related]  

  • 6. Readers' and author's responses to "We all need healthcare; who needs 'insurance'?".
    Polaschek J
    MedGenMed; 2007; 9(4):13; author reply 13. PubMed ID: 18320630
    [No Abstract]   [Full Text] [Related]  

  • 7. Readers' and author's responses to "We all need healthcare; who needs 'insurance'?".
    Rinsler S
    MedGenMed; 2007; 9(4):13; author reply 13. PubMed ID: 18320631
    [No Abstract]   [Full Text] [Related]  

  • 8. Readers' responses to "the cost of marginal medicine is too high".
    Levin GM
    MedGenMed; 2006 May; 8(2):44; author reply 43. PubMed ID: 16926782
    [No Abstract]   [Full Text] [Related]  

  • 9. Readers' responses to "the cost of marginal medicine is too high".
    Blanchet WL
    MedGenMed; 2006; 8(2):44; author reply 43. PubMed ID: 17048328
    [No Abstract]   [Full Text] [Related]  

  • 10. Readers' and author's responses to "We all need healthcare; who needs 'insurance'?".
    Hunt J
    MedGenMed; 2007; 9(4):13; author reply 13. PubMed ID: 18320633
    [No Abstract]   [Full Text] [Related]  

  • 11. [Costs attributed to hospital-acquired infections].
    Pedersen KM; Kolmos HJ
    Ugeskr Laeger; 2007 Nov; 169(48):4135-8. PubMed ID: 18211775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Readers' perspective. The benefits cf pay-for-performance programs are worth the cost and hassles to provider organizations to participate.
    Linares A; Gauthier P; Isaacs C; Barnett P; Gamache E; Kerchief KR
    Health Data Manag; 2007 Dec; 15(12):10. PubMed ID: 18203598
    [No Abstract]   [Full Text] [Related]  

  • 13. Measuring the effects of lifestyle interventions on health care costs.
    Manheim LM
    J Am Diet Assoc; 2007 Aug; 107(8):1307-10. PubMed ID: 17659895
    [No Abstract]   [Full Text] [Related]  

  • 14. [Health-care costs and health technology assessment].
    Lettieri E; Masella C
    G Ital Nefrol; 2007; 24 Suppl 40():s22-36. PubMed ID: 18034409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-inclusive evaluation: a banquet of approaches for including costs, benefits, and cost-effectiveness and cost-benefit analyses in your next evaluation.
    Yates BT
    Eval Program Plann; 2009 Feb; 32(1):52-4. PubMed ID: 18977532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Health care and society have to pay a high price for rotavirus infections in children. A Swedish descriptive cost analysis study].
    Bergman A; Young C; Miadi-Fargier H; Gothefors L
    Lakartidningen; 2008 Apr 16-22; 105(16):1186-91. PubMed ID: 18522259
    [No Abstract]   [Full Text] [Related]  

  • 19. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
    Delong LK; Culler SD; Saini SS; Beck LA; Chen SC
    Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Economic effects of "molecular" medicine].
    Riemann JF
    Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1740. PubMed ID: 17713881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.